The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
70
The intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme.
Copenhagen University Hospital Rigshospital
Copenhagen, Denmark
Herlev Hospital
Herlev, Denmark
Six Minute Walk Distance 6MWD
Change in distance in meter
Time frame: Change from baseline in 6MWD at 12 weeks
Estimated VO2 max Aastrand test
Change in l/m
Time frame: Change from baseline in VO2 Aastrand test at 12 weeks
Timed chair stand
Change in number of repetitions
Time frame: Change from baseline in timed chair stand at 12 weeks
Timed biceps curl
Change in number of repetitions
Time frame: Change from baseline in timed bicep curl at 12 weeks
EORTC QLQ-C30
Change in scores for quality of life
Time frame: Change from baseline in EORTC QLQ-C30 at 12 weeks
FACT-An
Change in scores for quality of life/function
Time frame: Change from baseline in FACT-An at 12 weeks
HADS
Change in scores for emotional wellbeing
Time frame: Change from baseline in HADS at 12 weeks
SF36
Change in scores for general health
Time frame: Change from baseline in SF36 at 12 weeks
MDASI
Change in scores for symptom burden
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Change from baseline over time (1,2,3,4,5,6,7,8,9,10,11,12 weeks)